Exelixis, Inc.

Type	Public (NYSE:EXEL)
Founded	1994
Headquarters	South San Francisco, California, USA
Key people	George Scangos, CEO Michael Morrissey, President, Research and Development Frank Karbe, CFO Gisela M. Schwab, Executive Vice President and Chief Medical Officer Pamela A. Simonton, Executive Vice President and General Counsel Peter Lamb, Senior Vice President, Discovery Research and Chief Scientific Officer Lupe M. Rivera, Senior Vice President, Operations
Industry	Biotechnology
Website	http://www.exelixis.com/

Exelixis is a genomics-based drug discovery company located in South San Francisco, Ca. It works on the development of anti-cancer therapies. Exelixis has several compounds in various stages of FDA approval and is listed on NASDAQ (EXEL).

[edit] External links

• Exelixis

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. v • d • e